InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,082.68
(
-2.09%
)
Post# of 252503
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 44
Posts 4597
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 207434

Friday, 12/30/2016 11:25:48 AM

Friday, December 30, 2016 11:25:48 AM

Post# of 252503
I think it is "popular in these parts" in part bc it does NOT have a lot of moving parts and is fairly easy to understand- all of 2 programs, w one accounting for 90% of the current valuation
I do think competition from biosimilar epo, competition from future HIFPH inhibitors, risk inherent w a novel MOA and the fairly high market cap for a development stage bio are all reasonable concerns of course
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up